Telemedicine and Social Media for People Who Inject Drugs (PWID) in Greece

NCT ID: NCT05794984

Last Updated: 2024-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

219 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-02

Study Completion Date

2023-09-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current study seeks to address questions regarding internet and social media usage as well as telemedicine concept and knowledge, by conducting targeted focus group discussions (FGDs) and administering cross-sectional questionnaires among PWID in Greece. Further parameters, such as perceptions for high-quality healthcare access, confidentiality, privacy, and security, will also be explored.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study's aim is to access the feasibility, acceptability and accessibility of social media and telemedicine as methods to obtain healthcare, in order to improve linkage-to-care among Greek substance users. Underserved populations, such as people who inject drugs (PWID) have limited access to healthcare and a potential solution to expanding healthcare access points is telemedicine. For the past decade, the investigators have studied the efficacy of a facilitated telemedicine model for hepatitis C virus (HCV) treatment integrated into opioid treatment programs (OTPs) for PWIDs. The investigators have achieved high rates of HCV resolution and high patient-satisfaction through facilitated telemedicine. The investigators now seek to explore whether this same intervention might be feasible and acceptable in Greece. The first step is to capture and explore the current knowledge, experiences, believes, perceptions and attitudes of PWID in Greece regarding internet and social media usage and telemedicine concept, through targeted Focus Group Discussions (FGDs) and administration of cross-sectional questionnaire. The perceptions for high-quality healthcare, confidentiality, privacy and security matters will also be explored as well as further relevant attributes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Abuse, Intravenous Internet Social Media Telemedicine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Targeted Focus Group Discussions and Cross-sectional questionnaire

57 people for targeted Focus Group Discussions 162 people for Cross-sectional questionnaire

Focus group discussions and survey questionnaire

Intervention Type OTHER

Questions regarding internet and social media usage, as well as telemedicine concept and knowledge. Assessment of the feasibility, acceptability and accessibility of social media and telemedicine as methods to obtain healthcare. Perceptions for high-quality healthcare access, confidentiality, privacy, and security, will also be explored.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Focus group discussions and survey questionnaire

Questions regarding internet and social media usage, as well as telemedicine concept and knowledge. Assessment of the feasibility, acceptability and accessibility of social media and telemedicine as methods to obtain healthcare. Perceptions for high-quality healthcare access, confidentiality, privacy, and security, will also be explored.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \>18 years old
* PWID
* Willing and able to provide informed consent and participate
* Fluent in Greek spoken language
* Internet access


* \>18 years old
* PWID
* Willing and able to provide informed consent and participate
* Fluent in Greek spoken language

Exclusion Criteria

* \<18 years old
* Unable/unwilling to consent
* Legally incompetent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases

OTHER

Sponsor Role collaborator

State University of New York at Buffalo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrew Talal

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrew Talal, MD

Role: PRINCIPAL_INVESTIGATOR

University at Buffalo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Prometheus

Athens, , Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

References

Explore related publications, articles, or registry entries linked to this study.

Talal AH, Andrews P, Mcleod A, Chen Y, Sylvester C, Markatou M, Brown LS. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone. Clin Infect Dis. 2019 Jul 2;69(2):323-331. doi: 10.1093/cid/ciy899.

Reference Type BACKGROUND
PMID: 30329042 (View on PubMed)

Talal AH, McLeod A, Andrews P, Nieves-McGrath H, Chen Y, Reynolds A, Sylvester C, Dickerson SS, Markatou M, Brown LS. Patient Reaction to Telemedicine for Clinical Management of Hepatitis C Virus Integrated into an Opioid Treatment Program. Telemed J E Health. 2019 Sep;25(9):791-801. doi: 10.1089/tmj.2018.0161. Epub 2018 Oct 16.

Reference Type BACKGROUND
PMID: 30325701 (View on PubMed)

Talal AH, Markatou M, Sofikitou EM, Brown LS, Perumalswami P, Dinani A, Tobin JN. Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C). Contemp Clin Trials. 2022 Jan;112:106632. doi: 10.1016/j.cct.2021.106632. Epub 2021 Nov 20.

Reference Type BACKGROUND
PMID: 34813962 (View on PubMed)

Talal AH, Sofikitou EM, Wang K, Dickerson S, Jaanimagi U, Markatou M. High Satisfaction with Patient-Centered Telemedicine for Hepatitis C Virus Delivered to Substance Users: A Mixed-Methods Study. Telemed J E Health. 2023 Mar;29(3):395-407. doi: 10.1089/tmj.2022.0189. Epub 2022 Aug 4.

Reference Type BACKGROUND
PMID: 35925809 (View on PubMed)

Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, Panopoulos A, Malliori M, Psichogiou M, Pharris A, Wiessing L, van de Laar M, Donoghoe M, Heckathorn DD, Friedman SR, Des Jarlais DC. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction. 2015 Sep;110(9):1453-67. doi: 10.1111/add.12999. Epub 2015 Jul 14.

Reference Type BACKGROUND
PMID: 26032121 (View on PubMed)

Sypsa V, Psichogiou M, Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Micha K, Malliori M, Pharris A, Wiessing L, Donoghoe M, Friedman S, Jarlais DD, Daikos G, Hatzakis A. Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens. J Infect Dis. 2017 May 15;215(10):1496-1505. doi: 10.1093/infdis/jix100.

Reference Type BACKGROUND
PMID: 28407106 (View on PubMed)

Papalamprakopoulou Z, Roussos S, Ntagianta E, Triantafyllou V, Kalamitsis G, Dharia A, Sypsa V, Hatzakis A, Talal AH. Considerations for equitable distribution of digital healthcare for people who use drugs. BMC Health Serv Res. 2025 Apr 10;25(1):531. doi: 10.1186/s12913-025-12619-7.

Reference Type DERIVED
PMID: 40211324 (View on PubMed)

Papalamprakopoulou Z, Ntagianta E, Triantafyllou V, Kalamitsis G, Dharia A, Dickerson SS, Hatzakis A, Talal AH. Telehealth to increase healthcare access; perspectives of people who use drugs. BMC Med Inform Decis Mak. 2024 Oct 19;24(1):306. doi: 10.1186/s12911-024-02718-6.

Reference Type DERIVED
PMID: 39425182 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.respondentdrivensampling.org/reports/steering.pdf

Extensions of Respondent-Driven Sampling: Analyzing Continuous Variables and Controlling for Differential Recruitment

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00007088

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MDMA-Assisted Therapy for Pathological Narcissism
NCT06565494 RECRUITING EARLY_PHASE1
Behavioral Effects of Pregabalin and Cannabis
NCT01511640 COMPLETED EARLY_PHASE1
Personality and Drug Use (PDU)
NCT05180149 WITHDRAWN
Substance Use Disorder in Chemsex Practice
NCT06476873 NOT_YET_RECRUITING NA